Acarix
0.545 SEK -0.91%1 investor is following this company
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACARIX
Daily low / high price
0.525 / 0.557
SEK
Market cap
563.08M SEK
Turnover
1.79M SEK
Volume
3.3M
Financial calendar
Interim report
22.08.2024
Interim report
07.11.2024
Annual report
13.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Försäkringsaktiebolaget, Avanza Pension | 6.3 % | 6.3 % |
Mikael Thorén | 3.9 % | 3.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Acarix Receives Sizeable Patch Reorder from Louisiana Primary Care Clinic
Acarix receives additional multi unit order from In-Home Concierge Practice
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools